Related Experiment Video
Updated: May 31, 2026

A Thin-skull Window Technique for Chronic Two-photon In vivo Imaging of Murine Microglia in Models of Neuroinflammation
Published on: September 19, 2010
Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat
Daniel Fraga1, Erinn S Raborn, Gabriela A Ferreira
1Department of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University, 1101 E. Marshall St., Richmond, VA 23298, USA.
Abstract:
Microglia are a population of macrophage-like cells in the central nervous system (CNS) which, upon infection by the human immunodeficiency virus (HIV), secrete a plethora of inflammatory factors, including the virus-specified trans-activating protein Tat. Tat has been implicated in HIV neuropathogenesis since it elicits chemokines, cytokines, and a chemotactic response from microglia. It also harbors a β-chemokine receptor binding motif, articulating a mode by which it acts as a migration stimulus. Since select cannabinoids have anti-inflammatory properties, cross the blood-brain barrier, and target specific receptors, they have potential to serve as agents for dampening untoward neuroimmune responses. The aim of this study was to investigate the effect of select cannabinoids on the migration of microglial-like cells toward Tat. Using a mouse BV-2 microglial-like cell model, it was demonstrated that the exogenous cannabinoids Delta-9-tetrahydrocannabinol (THC) and CP55940 exerted a concentration-related reduction in the migration of BV-2 cells towards Tat. A similar inhibitory response was obtained when the endogenous cannabinoid 2-arachidonoylglycerol (2-AG) was used. The CB(2) receptor (CB2R) antagonist SR144528, but not the CB(1) receptor (CB1R) antagonist SR141716A, blocked this inhibition of migration. Similarly, CB2R knockdown with small interfering RNA reversed the cannabinoid-mediated inhibition. In addition, the level of the β-chemokine receptor CCR-3 was reduced and its intracellular compartmentation was altered. These results indicate that cannabinoid-mediated inhibition of BV-2 microglial-like cell migration to Tat is linked functionally to the CB2R. Furthermore, the results indicate that activation of the CB2R leads to altered expression and compartmentation of the β-chemokine receptor CCR-3.
Insights
Cannabinoids like THC reduce microglial cell migration towards HIV Tat protein by activating the CB2 receptor. This suggests cannabinoids may help manage HIV-related neuroinflammation by controlling microglial movement.
Area of Science:
- Neuroimmunology
- Pharmacology
- Virology
Background:
- Microglia, the immune cells of the central nervous system (CNS), release inflammatory factors, including HIV Tat protein, contributing to HIV neuropathogenesis.
- HIV Tat protein stimulates microglial migration via beta-chemokine receptors, exacerbating neuroinflammation.
- Cannabinoids possess anti-inflammatory properties and can cross the blood-brain barrier, offering potential therapeutic avenues for neuroimmune disorders.
Purpose of the Study:
- To investigate the effects of specific cannabinoids on microglial cell migration induced by HIV Tat protein.
- To determine the role of cannabinoid receptors, specifically CB1R and CB2R, in mediating these effects.
Main Methods:
- Utilized a mouse BV-2 microglial cell model to assess migration towards Tat.
- Administered exogenous cannabinoids (Delta-9-tetrahydrocannabinol [THC], CP55940) and an endogenous cannabinoid (2-arachidonoylglycerol [2-AG]).
- Employed CB1R and CB2R antagonists (SR141716A, SR144528) and CB2R knockdown via small interfering RNA (siRNA) to elucidate receptor involvement.
- Analyzed changes in the beta-chemokine receptor CCR-3 expression and localization.
Main Results:
- Exogenous and endogenous cannabinoids significantly reduced BV-2 cell migration towards Tat in a concentration-dependent manner.
- The inhibitory effect was blocked by the CB2R antagonist SR144528 but not by the CB1R antagonist SR141716A.
- CB2R knockdown reversed the cannabinoid-mediated inhibition of migration.
- Cannabinoid treatment altered the expression and intracellular compartmentation of the beta-chemokine receptor CCR-3.
Conclusions:
- Cannabinoid-mediated inhibition of microglial migration to HIV Tat is functionally linked to the CB2 receptor.
- Activation of CB2R by cannabinoids modulates the expression and localization of CCR-3, impacting microglial response to Tat.
- These findings highlight the therapeutic potential of CB2R-targeting cannabinoids in managing HIV-associated neuroinflammation.
Related Concept Videos
Drugs that Stabilize Microtubules
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Inhibitors of Virion Maturation and Assembly
Drugs that Destabilize Microtubules
Microtubule Associated Proteins (MAPs)
Cryptococcal Meningitis
